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S U M M A R Y
Objective: To determine the prevalence of human papillomavirus (HPV) infection and genotype
distribution in Mexican women with similar lifestyles from two geographical regions who receive
medical care from theMexican Navy Health System, and to identify the associated sociodemographic and
reproductive characteristics.
Methods: Cervical swabs from 671 women, beneﬁciaries of the Mexican Navy Health System, from two
distinct southern coast regions of Mexico, were analyzed. Data were obtained regarding socio-
demographic variables and sexual and reproductive history. For HPV detection and typing, PCR with
general primers and direct sequencing were performed on extracted DNA. Association with clinical
variables was evaluated.
Results: Most patients had a normal cytology or low-grade intraepithelial neoplasia. A high prevalence of
HPVwas found (43.6%), with a signiﬁcant difference between the two regions studied from the southwest
Paciﬁc coast of Mexico (37.6% in Acapulco, Guerrero vs. 49.7% in La´zaro Ca´rdenas, Michoaca´n). Some
differences were also found associated to HPV type distribution, particularly related to genotypes 18, 58,
and 53. Factors inﬂuencing these differences could not be identiﬁed with the analysis of typical risk
factors linked to the acquisition of an HPV infection.
Conclusions: Regional differences in HPV prevalence and distribution show an apparent geographic
boundary between the studied populations that deserves further analysis, taking into account other
factors such as those related to the sexual partners.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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journa l homepage: www.e lsev ier .com/ locate / i j idCervical cancer is the second most common cancer among
women worldwide.1 High incidence rates of cervical cancer occur
in developing countries.2,3 Latin America and the Caribbean
contribute with 83.9% of the cases and 81.2% of deaths for the
total estimated cases.3 In Mexico, nearly 12,516 women are
diagnosed with cervical cancer each year, and 5777 die from this
disease.4 Nevertheless, cervical cancer mortality shows heteroge-
neity in different regions ofMexico.5 Although a national screening
program has been implemented to detect potentially preventable
cases,6 during the last three decades, a high rate of mortality has
persisted in more resource-limited areas, especially in the
southern region of Mexico.7 In particular, the incidence of cervical* Corresponding author. Tel.: +52 55 55734662.
E-mail address: lizano@servidor.unam.mx (M. Lizano).
1201-9712/$36.00 – see front matter  2010 International Society for Infectious Disea
doi:10.1016/j.ijid.2010.07.007cancer in Mexico is about twice as high in the coastal regions than
in the central part of the country.7 An analysis of mortality rates in
urban and rural Mexican communities determined that cervical
cancer mortality is associated with poverty-related factors,
including lack of formal education, unemployment, low socioeco-
nomic level, and insufﬁcient access to health care.8
Persistent infection with ‘high-risk’ types of human papilloma-
virus (HPV) is the biological cause of cervical cancer.9 Certain
patterns of sexual behavior, such as an early age at initiation of
sexual intercourse and the number of sexual partners, are
associated with an increased risk of genital HPV acquisition. Co-
factors, such as high parity, long-term use of oral contraceptives,
smoking, and co-infectionwithHIV, have also been associatedwith
cervical cancer progression.10
HPV prevalence varies from 2% to 44% worldwide and
geographical variations in HPV type distribution are also knownses. Published by Elsevier Ltd. All rights reserved.
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differences in HPV distribution may have an impact on the
effectiveness of the HPV vaccine in different populations.13
Few studies have been performed to compare HPV prevalence
and distribution in women with normal cytology across different
regions of Mexico, and information available is mainly focused on
the central part of the country.14–18 The aim of this study was to
determine the HPV prevalence and type distribution in Mexican
populations from two distinct southern coast geographical regions,
sharing lifestyle characteristics including access to similar health
care services, and to identify associated sociodemographic and
reproductive traits.
1. Methods
1.1. Study population
The women studied were beneﬁciaries of the Mexican Navy
Health System, either by being active duty navy personnel or their
dependants.Womenwere invited to participate in this study at the
Hospital Naval of Acapulco, Guerrero, and at the Sanatorio Naval of
La´zaro Ca´rdenas, Michoaca´n. A total of 717 women aged between
18 and 81 yearswere recruited for the analysis. Thesewomenwere
apparently in good health, had not undergone any cervicovaginal
treatment during the previous 3 months, and were not pregnant.Table 1
Association between HPV-DNA positivity and sociodemographic variables.
Variable Negative, n (%)a
Number of women 378
Age, mean (SD) 38.0 (11.7)
Residence
Acapulco 209 (55.3)
La´zaro Ca´rdenas 169 (44.7)
Status in Mexican navy
Personnel 20 (5.4)
Dependent 349 (94.6)
Marital status
Single 83 (22.3)
Married 289 (77.7)
Education, median Junior high school
Working status
None 26 (6.9)
Irregular trade 348 (92.1)
Formal employment 4 (1.1)
Condom use
Yes 124 (34.5)
No 235 (65.5)
Number of lifetime sexual partners
1–2 150 (43.5)
3 or more 195 (56.5)
Pregnancy
Yes 341 (90.2)
No 37 (9.8)
Number of live births, median 3
Pregnancy problems
Yes 47 (13.9)
No 292 (86.1)
Venereal disease
Yes 229 (62.2)
No 139 (37.8)
Age at menarche, mean (SD) 13.5 (2.7)
Age at initiation of sexual intercourse, mean (SD) 18.8 (3.5)
Familial cancer
Uterine 57 (15.1)
Breast 40 (10.6)
None of the above 281 (74.3)
HPV, human papillomavirus; SD, standard deviation.
a Data within parentheses are vertical percentages, except where otherwise speciﬁe
b Probability value for the comparison of HPV-negative vs. HPV-positivewomen; tests u
appropriate.All women agreed to provide information about their medical
history, and written informed consent was obtained according to
the recommendations of the ethics review boards of the Direccio´n
General Adjunta de Sanidad Naval, Secretarı´a de Marina and the
Instituto Nacional de Cancerologı´a of Mexico. Data were obtained
regarding sociodemographic variables and sexual and reproduc-
tive history. Two cervical cell scrapings were taken with a
cytobrush from both the ectocervix and endocervix. One of the
specimens was subjected to routine cytological analysis. Samples
were read by a single pathologist from the Navy Medical School
and were classiﬁed according to the Bethesda System. Observed
abnormalities and 10% of negative cases were re-examined by a
cytologist from the Instituto Nacional de Cancerologı´a of Mexico.
The second specimen was processed for DNA extraction.
1.2. HPV detection and typing
DNAwas extracted directly from cervical swab samples with an
Eppendorf kit in accordance with the manufacturer’s protocol, and
DNA was PCR-ampliﬁed for the b-globin gene (primers GH20/
PC04) as recommended by Resnick et al.19 HPV testing was
performed by PCR with universal L1 primers MY09/11, GP5/6, and
L1C1/C2, as previously described.19–21 Positive controls consisted
of DNA fromHeLa and Caski cell lines. Mixtures without DNAwere
included as negative controls. HPV-positive samples were directlyPositive, n (%)a Total p-Valueb
293 671
36.9 (12.3) 0.186
126 (43.0) 335 0.001
167 (57.0) 336
14 (4.8) 34 0.860
277 (95.2) 626
76 (25.9) 159 0.276
217 (74.1) 506
Junior high school 0.90
27 (9.2) 53 0.329
265 (90.4) 613
1 (0.3) 5
94 (32.8) 218 0.676
193 (67.2) 428
128 (46.5) 278 0.465
147 (53.5) 342
264 (90.1) 605 1.000
29 (9.9) 66
3 0.966
41 (15.3) 88 0.643
227 (84.7) 519
181 (62.8) 410 0.945
107 (37.2) 246
13.2 (2.0) 0.211
18.5 (3.5) 0.148
39 (13.3) 96 0.173
45 (15.4) 85
209 (71.3) 490
d. In some cases a few data were missing.
sedwere rank-sum test, Fisher’s exact test, or Chi-square contingency tables test, as
Table 2
Sociodemographic variables analyzed by geographic region.
Variable Acapulco, n (%)a La´zaro Ca´rdenas, n (%)a p-Valueb
Number of women 335 336
Age, mean (SD) 41.2 (12.8) 33.9 (9.8) 0.000
Age at menarche, mean (SD) 13.4 (1.6) 13.3 (2.9) 0.0041
Navy personnel 12 (3.6) 22 (6.5) 0.081
Marital status single 97 (29.0) 62 (18.5) 0.001
Education (median) Junior high school Junior high school 0.125
Working status
None 29 (8.7) 24 (7.1) 0.062
Irregular trade 306 (91.3) 307 (91.4)
Formal employment 0 5 (1.5)
Condom use yes 101 (32.3) 117 (35.1) 0.455
Age at initiation of sexual intercourse, mean (SD) 18.8 (3.75) 18.6 (3.22) 0.950
Number of lifetime sexual partners
1–2 141 (47.2) 137 (42.7) 0.294
3 or more 158 (52.8) 184 (57.3)
Pregnancies, mean (SD) 3.7 (2.96) 3.0 (2.226) 0.0104
HPV type
High risk 82 (65.1) 111 (66.5) 0.858
Low risk 24 (19.0) 30 (18.0)
Unsequenced 20 (15.9) 26 (15.5)
SD, standard deviation; HPV, human papillomavirus.
a Data within parentheses are vertical percentages, except where otherwise speciﬁed. In some cases a few data were missing.
b Probability value for the comparison of Acapulco vs. La´zaro Ca´rdenas geographic regions; tests used were rank-sum test, Fisher’s exact test, or Chi-square contingency
tables test, as appropriate.
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(Applied Biosystems, New Jersey USA). HPV sequences were
analyzed with the BLAST NCBI GenBank program (http://
www.ncbi.nlm.nih.gov).
1.3. Statistical analysis
Statistical comparisonswereperformedwith the Fisher–Halton–
Freeman exact procedure for the Chi-square test in the case of
contingency tables.22 For ordinal variables, we used the rank sum
test for two independent samples.23 Logistic regressionmodelswere
built to identify the independent effect of a given variable on a
certain outcome (presence of HPV or being from a certain location).
To analyze HPV type distribution within each location, we used the
Shannon–Wiener homogeneity index.23 The alpha level was set to
0.05. Calculations were performed using Stata (v. 7) and StatX-act
software (Stata Corp., College Station, TX, USA).
2. Results
2.1. HPV status and clinical variables
Forty-six out of 717 collected samples were excluded from the
study because the extracted DNA was not suitable for PCR
ampliﬁcation (b-globin-negative). HPV detection and typing were
performed for the remaining 671 samples. Normal cytology or
inﬂammation was reported in 551 of 671 samples (82.1%). Sixty-
one cases showed low-grade squamous intraepithelial lesionsTable 3
Association of HPV positivity and location by means of multivariate adjustment analys
Dependent variable Independent variable OR
HPV Site 1.70
HPV Site 1.66
Age 0.999
HPV Site 1.70
Age 0.998
Marital status 0.77
HPV Age 0.992
Site Age 0.945
HPV, human papillomavirus; OR, odds ratio; CI, conﬁdence interval.(LSIL) (9.1%) and eight cases had high-grade squamous intrae-
pithelial lesions (HSIL) (1.2%); one case of cervical cancer was
detected. Fifty samples were not adequate for cytological analysis
(7.5%). Table 1 shows the descriptive values of the studied
variables according to HPV positivity. Cytological results were
similar between HPV-positive and HPV-negative samples.
Half of the studiedwomenwere from Acapulco (335 cases), and
the other half from La´zaro Ca´rdenas (336 cases). Women were
primarily in their mid 30s, and most were married (75%) and had a
median education level of junior high school. Two hundred and
ninety-three of 671 women tested positive for HPV (43.7%).
Variables were analyzed to ﬁnd any association with HPV
positivity. The only statistically signiﬁcant association was a
higher HPV presence in women from La´zaro Ca´rdenas compared to
those from Acapulco (49.7% vs. 37.6%; p = 0.001).
2.2. Association between sociodemographic variables and location
When searching for a possible explanation for the difference in
HPV positivity, we found that women from La´zaro Ca´rdenas were
younger (33.9 vs. 41.2 years; p = 0.000), more frequently married
(81.5% vs. 71.0%; p = 0.001), and had a slightly lower average
number of pregnancies (3.0 vs. 3.7; p = 0.010) (Table 2). In terms of
high- or low-risk HPV type distribution, no difference was found
between locations (p = 0.858), the high-risk types being more
prevalent.
The association of HPV and location remained signiﬁcant even
after a multivariate adjustment for age and marital status wasis.
95% CI p-Value p-Value for model
1.25–2.31 0.001 0.0007
1.20–2.30 0.002 0.0047
0.985–1.018 0.873
1.22–2.35 0.002 0.0055
0.984–1.011 0.725
0.53–1.11 0.162
0.980–1.005 0.252 0.251
0.931–0.959 0.000 0.0000
Table 4
HPV genotype distribution according to site.
Genotype Acapulco, n (%) La´zaro Ca´rdenas, n (%)
16 35 (27.8) 34 (20.4)
18 14 (11.1) 10 (6.0)
58 5 (4.0) 18 (10.8)
11 5 (4.0) 12 (7.2)
53 11 (8.7) 5 (3.0)
35 2 (1.6) 8 (4.8)
45 1 (0.8) 8 (4.8)
61 4 (3.2) 5 (3.0)
31 3 (2.4) 6 (3.6)
81 2 (1.6) 5 (3.0)
70 3 (2.4) 1 (0.6)
52 2 (1.6) 2 (1.2)
83 2 (1.6) 1 (0.6)
85 2 (1.6) 1 (0.6)
71 1 (0.8) 2 (1.2)
90 2 (1.6) 1 (0.6)
68 1 (0.8) 1 (0.6)
66 1 (0.8) 1 (0.6)
39 1 (0.8) 1 (0.6)
56, 44, 13, 84, 42 1 case each (0.8) –
6, 72 2 cases each (1.6) –
33 – 8 (4.8)
51 – 4 (2.4)
89 – 3 (1.8)
59 – 2 (1.2)
82, 87 – 1 case each (0.6)
NDa 20 (15.9) 26 (15.6)
Underlined types correspond to ‘low risk’ genotypes, as determined by de Villiers
et al.24
a ND: HPV genotype could not be determined in 46 HPV-positive cases.
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only signiﬁcant association, when location was regarded as the
dependant variable, was with age.
Therefore, it may be concluded that the primary determinant of
variation for HPV prevalence in this study is the site, and is not
explained by differences in age or other usual risk factors.
2.3. HPV genotype distribution
HPV genotype could be determined for 247 of 293 HPV-positive
samples; the other 46HPV-positive cases could not be typed by the
BLAST analysis. Type distribution is shown in Table 4. Thirty-two
different HPV types were found in this study, with 18 of them
corresponding to high-risk types according to de Villiers et al.24
High- and low-risk HPV genotypes corresponded to 65.8% and
18.4% of samples, respectively. HPV16 and phylogenetically related
types (52, 58, 33, 31, and 35) were found in 41.9% of samples, while
HPV18 and related types (70, 68, 39, 59, 85, and 45) were found in
15.7% of the cases. HPV16 was the most common type, accounting
for 69 cases (23.5%). The next most common types were HPV18
with 24 cases (8.2%), HPV58 with 23 cases (7.8%), HPV11 with 17
cases (5.8%), HPV53 with 16 cases (5.5%), and HPV35 with 10 cases
(3.4%). The other viral types were found in fewer than 10 samples
each. No signiﬁcant differences in HPV type distribution were
found with respect to age (data not shown).
A statistical comparison of the Shannon–Wiener index of
homogeneity between the two studied locations was performed to
analyze HPV distribution according to region. There was no
signiﬁcant difference (0.768 in Acapulco vs. 0.720 in La´zaro
Ca´rdenas; p > 0.1). Nevertheless, when analyzing the most
frequent HPV types separately, signiﬁcant differences related to
genotypes 18, 58, and 53 were observed. HPV18 was present in
11.1% of the HPV-positive cases in Acapulco vs. 6.0% in La´zaro
Ca´rdenas (Fisher’s exact test p = 0.022). HPV58 was present in
10.8% of HPV cases in La´zaro Ca´rdenas, while only 4.0% of cases
corresponded to this type in Acapulco (p = 0.049). Finally, HPV53was present in 8.7% of Acapulco’s positive cases but was only
present in 3.0% of the cases from La´zaro Ca´rdenas (p = 0.037). It is
worth mentioning that some HPV types were exclusively found in
one location. Viral genotypes restricted to Acapulco were 44, 6, 13,
56, 84, 72, and 42; whereas HPV types 89, 51, 59, 87, 82, and 33
were only found in La´zaro Ca´rdenas.
3. Discussion
This study focused onwomen beneﬁciaries of theMexicanNavy
Health System who live in two geographically separate cities on
the southwest coast of Mexico: Acapulco, Guerrero, and La´zaro
Ca´rdenas, Michoaca´n. Since the great majority of women
participating in this study had a normal cervical cytology, the
high prevalence of HPV (43.6%) is noteworthy. Most of the HPV
genotypes found corresponded to high-risk types (65.8% of positive
cases), conﬁrming a high prevalence of asymptomatic carriers. Our
results may shed light on the higher relative risk of death from
cervical cancer (1.23) reported for southern Mexican states
bordering the Paciﬁc coast, as compared with the country as a
whole.7
The prevalence of HPV found in this study is so far the highest
reported from various regions of Mexico, with previously reported
prevalence varying between 11% and 35%.14–18,25,26 However, the
results of this study are consistent with inter-regional variations
reported for other parts of the world,13,27 with a mean estimated
global prevalence of HPV infection in women with a normal
cytology of 10.4% and inter-regional variations between 2% and
44%.28 In Africa, America, and Europe, the highest frequency has
been reported for women younger than 35 years, with a second
peak for the group of women aged over 45 years.29 In the present
study, no signiﬁcant difference between the studied regions was
found related to age.
The most important result of this study was the signiﬁcant
difference found in HPV prevalence between the two regions. Half
of the women were HPV-positive in La´zaro Ca´rdenas; in contrast,
38% of the women from Acapulco were HPV-positive. To explain
this difference we analyzed variables classically related to HPV
acquisition (i.e., age, age at ﬁrst sexual intercourse, number of
lifetime sexual partners, education, parity, and condom use), and
found that women from La´zaro Ca´rdenas were signiﬁcantly
younger and with a lower parity. Other signiﬁcant differences
included a higher marriage rate in La´zaro Ca´rdenas, as well as a
discreetly lower age at menarche.
HPV positivity showed a clear associationwith location, but not
with age (Table 3). Furthermore, when both variables (location and
age) were introduced to elucidate their simultaneous effect, the
geographic location remained highly signiﬁcant (although at a
somewhat lesser value) and age did not reach signiﬁcance.
Additionally, there was no signiﬁcant effect after adjusting for
marital status, a variable differentially distributed across both
locations. Thus we may argue that there must be additional risk
factors, perhaps related to the sex partners, as has been previously
suggested,30 that could help to explain HPV acquisition.
Some important differences were found related to HPV
genotype distribution. The most frequent HPV genotype found
in our study was HPV16 for both regions. In La´zaro Ca´rdenas, the
next most common types were HPV58 and HPV11, while HPV18
came in fourth place. A previous study done in the southeastern
part ofMexico also showed a high prevalence of HPV58, being even
more prevalent than HPV18.31 Our results from the Acapulco
population showed that HPV18 was the second most common
type, followed byHPV53. Results obtained by Illades-Aguiar et al.25
in southern Mexico showed that HPV33 was the most prevalent
genotype, followed by HPV16 and HPV58. Calleja-Macı´as et al.16
identiﬁed HPV16 as highly prevalent in northeastern Mexico,
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regional variation in HPV type prevalence in women without
cytological abnormalities.
Another interesting ﬁnding of this study was that some HPV
genotypes were found exclusively in one region. This was the case
for genotypes 33, 51, 89, 59, 82, and 87, found only in La´zaro
Ca´rdenas (‘high-risk’ types except for HPV89 and HPV87); and
types 56, 44, 13, 84, 42, 6, and 72 found only in Acapulco (‘low-risk’
types except for HPV56). A geographic boundary between the
studied Paciﬁc coast populations with respect to HPV prevalence
and type distribution may exist. However, the factors inﬂuencing
HPV prevalence could not be identiﬁed by analyzing typical risk
factors associated with the acquisition of HPV.
It should be mentioned that 46 of the 293 (15.7%) HPV PCR-
positive samples found in this study could not be typed by the
BLAST analysis, even though a sequence of good quality was
obtained for some of them. A possible explanation for this is that
such samples contained multiple HPV types, resulting from mixed
infections, whose DNA sequences overlap. The presence of
multiple HPV infections is important and should be addressed
in further studies.
It could be argued that the inability to type almost 16% of the
HPV-positive samples introduces a bias in our estimation of HPV
type distribution. However, since the percentage of untyped
samples is similar for both locations (15.8% for Acapulco vs. 15.6%
for La´zaro Ca´rdenas), we consider that our estimates are a reliable
representation of the viral type distribution in both geographic
locations.
Differences in HPV prevalence and distribution between La´zaro
Ca´rdenas and Acapulco may be inﬂuenced by environmental,
cultural, or genetic factors. Features concerning population
activities could also provide important information to explain
population resettlement and HPV distribution. The results of this
study show signiﬁcant differences in HPV prevalence and type
distribution between the two populations, which could be
explained by the current dynamics of the populations, determined
by factors such as changes in lifestyle due to foreign inﬂuences,
diet, and habits that are relevant to health care; this merits further
analysis.32
An interesting diversity of HPV genotypes was found in this
study. The only signiﬁcant differences in HPV distribution between
the studied populations were related to types 18, 58, and 53.
Although we did not analyze HPV intra-type diversity and
distribution thereof, we acknowledge that it could be an important
source of variation that deserves attention. Epidemiological and
molecular data have conﬁrmed that variants of high-riskHPV types
may have different biological behaviors, explaining differences in
disease progression.33–36
Our data point to the necessity of improving cervical cancer
screening programs in the Mexican Paciﬁc coast regions due to an
important HPV prevalence involving high-risk types. Furthermore,
geographical differences in HPV prevalence and distribution found
in this study may have a potential impact on HPV vaccination
effectiveness that should be elucidated in future studies. Possible
geographic variations in speciﬁc areas also suggest a necessity for
designing polyvalent HPV vaccines, which include high-risk HPV
types that are more prevalent in speciﬁc regions.
Conﬂict of interest
No conﬂict of interest to declare.
Acknowledgements
This work was supported in part by the Instituto de Investiga-
cio´n y Desarrollo Tecnolo´gico de la Armada deMexico (INIDETAM)and by the Consejo Nacional de Ciencia y Tecnologı´a, Mexico
(CONACYT Salud-2004-C01-67/A-1 and Salud-2002-C01-6579/
A1). We thank Jorge Barbabosa, Marı´a del Socorro Rivera, Luis
Chevalier, and Levi Barbosa for technical assistance, and Elizabeth
Langley and Edmundo Lamoyi for critical review of themanuscript.
References
1. Bosch X, Mun˜oz N. The viral etiology of cervical cancer. Virus Res 2002;89:183–
90.
2. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002. Cancer incidence,
mortality and prevalence worldwide. IARC Cancer Base No. 5 version 2.0. Lyon,
France: IARC Press; 2004.
3. Lewis MJ. A situational analysis of cervical cancer in Latin America and the
Caribbean. Washington, DC: Pan American Health Organization; 2004.
4. World Health Organization. Human papillomavirus and related cancers. Sum-
mary report Mexico; 2010. Available at: http://www.who.int/hpvcentre, Janu-
ary 29, 2010. .
5. Denny L, Quinn M, Sankaranarayanan R. Screening for cervical cancer in
developing countries. Vaccine 2006;24(Suppl. 3):71–7 [chapter 8].
6. Flores YN, Bishai DM, Shah KV, Lazcano-Ponce E, Lo¨rincz A, Herna´ndez M, et al.
Risk factors for cervical cancer among HPV positive women in Mexico. Salud
Publica Mex 2008;50:49–58.
7. Palacio-Mejı´a LS, Lazcano-Ponce E, Allen-Leigh B, Herna´ndez-A´vila M. Difer-
encias regionales en lamortalidad por ca´ncer demama y ce´rvix enMe´xico entre
1979 y 2006. Salud Publica Mex 2009;51(Suppl. 2):S208–19.
8. Palacio-Mejı´a LS, Rangel-Go´mez G, Herna´ndez-Avila M, Lazcano-Ponce E. Cer-
vical cancer, a disease of poverty: mortality differences between urban and
rural areas in Mexico. Salud Publica Mex 2003;45(Suppl. 3):S315–25.
9. Bosch FX, de Sanjose S. Human papillomavirus and cervical cancer-burden and
assessment of causality. J Natl Cancer Inst Monogr 2003;31:3–13 [chapter 1].
10. Almonte M, Albero G, Molano M, Carcamo C, Garcı´a P, Pe´rez G. Risk factors for
human papillomavirus exposure and co-factors for cervical cancer in Latin
America and the Caribbean. Vaccine 2008;26(Suppl. 11):L16–36.
11. Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, et al.
Epidemiology and natural history of human papillomavirus infections and
type-speciﬁc implications in cervical neoplasia. Vaccine 2008;26(Suppl.
10):K1–6.
12. de Sanjose´ S, Diaz M, Castellsague´ X, Clifford G, Bruni L, Mun˜oz N, et al.
Worldwide prevalence and genotype distribution of cervical human papillo-
mavirus DNA inwomenwith normal cytology: ameta-analysis. Lancet Infect Dis
2007;7:453–9.
13. Mammas IN, Vageli D, Spandidos DA. Geographic variations of human papillo-
ma virus infection and their possible impact on the effectiveness of the
vaccination programme. Oncol Rep 2008;20:141–5.
14. Torroella-Kouri M,Morsberger S, Carrillo A, Mohar A, Meneses A, IbarraM, et al.
HPV prevalence among Mexican women with neoplastic and normal cervixes.
Gynecol Oncol 1998;70:115–20.
15. Lazcano-Ponce E, Herrero R, Mun˜oz N, Cruz A, Shah KV, Alonso P, et al.
Epidemiology of HPV infection among Mexican women with normal cervical
cytology. Int J Cancer 2001;91:412–20.
16. Calleja-Macı´as IE, Kalantari M, Huh J, Ortiz-Lopez R, Rojas-Martinez A, Gonza-
lez-Guerrero JF, et al. Genomic diversity of human papillomavirus-16, 18, 31,
and 35 isolates in a Mexican population and relationship to European, African,
and Native American variants. Virology 2004;319:315–23.
17. Lopez-Revilla R, Martinez-Contreras L, Sanchez-Garza M. Prevalence of high-
risk human papillomavirus types in Mexican women with cervical intraepithe-
lial neoplasia and invasive carcinoma. Infect Agent Cancer 2008;3:3.
18. Velazquez-Marquez N, Paredes-Telo MA, Perez-Terron H, Santos-Lopez G,
Reyes-Leyva J, Vallejo-Ruiz V. Prevalence of human papillomavirus genotypes
in women from a rural region of Puebla, Mexico. Int J Infect Dis 2009;13:690–5.
19. Resnick R, Cornelissen M, Wright D, Eichnigen GH, Fox HS, Schegget J, et al.
Detection and typing of human papillomavirus in archival cervical cancer
specimens by DNA ampliﬁcation with consensus primers. J Natl Cancer Inst
1990;82:1477–84.
20. Husnjak K, Grce M, Magdic L, Paveli K. Comparison of ﬁve different polymerase
chain reaction methods for detection of human papillomavirus in cervical cell
specimens. J Virol Methods 2000;88:125–34.
21. Carrillo A, Mohar A, Meneses A, Frı´as-Mendivil M, Solorza G, Lizano M. Utilidad
en la combinacio´n de oligonucleo´tidos universales para la deteccio´n del virus
del papiloma humano en ca´ncer cervicouterino y lesiones premalignas. Salud
Publica Mex 2004;46:7–15.
22. Freeman GH, Halton JH. Note on an exact treatment of contingency, goodness of
ﬁt and other problems of signiﬁcance. Biometrika 1951;38:141–9 [Cited in:
CYTEL Software Corp. StatXact 4 for Windows. Statistical software for exact
nonparametric inference. User Manual. Cambridge: CYTEL; 1999, p. 614].
23. Zar JH. Biostatistical analysis, 4th ed., New Jersey: Prentice-Hall; 1999. p. 146–
56.
24. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classiﬁcation of
papillomaviruses. Virology 2004;324:17–24.
25. Illades-Aguiar B, Corte´s-Malago´n EM, Antonio-Ve´jar V, Zamudio-Lo´pez N,
Alarco´n-Romero LC, Ferna´ndez-Tilapa G, et al. Cervical carcinoma in southern
Mexico: human papillomavirus and cofactors. Cancer Detect Prev 2009;
32:300–7.
A. Orozco-Colı´n et al. / International Journal of Infectious Diseases 14 (2010) e1082–e1087 e108726. Sa´nchez-Anguiano LF, Alvarado-Esquivel C, Reyes-Romero MA, Carrera-Rodrı´-
guez M. Human papillomavirus infection in women seeking cervical Papani-
colaou cytology of Durango, Mexico: prevalence and genotypes. BMC Infect Dis
2006;6:27–32.
27. del Amo J, Gonza´lez C, Losana J, Clavo P, Mun˜oz L, Ballesteros J, et al. Inﬂuence of
age and geographical origin in the prevalence of high risk human papillomavi-
rus in migrant female sex workers in Spain. Sex Transm Infect 2005;81:79–84.
28. Arbyn M, Sasieni P, Meijer C, Clavel C, Koliopoulos G, Dillner J. Clinical applica-
tions of HPV testing: a summary of meta-analyses. Vaccine 2006;24(Suppl.
3):78–89 [Chapter 9].
29. Smith JS, Melendy A, Rana RK, Pimenta JM. Age-speciﬁc prevalence of infection
with human papillomavirus in females: a global review. J Adolesc Health
2008;43:S5–25.
30. Burchell AN, Teller PP, Hanley J, Coutlee F, Franco EL. Inﬂuence of partner’s
infection status on prevalent human papillomavirus among personswith a new
sex partner. Sex Transm Dis 2010;37:34–40.
31. Gonza´lez-Losa M, Rosado-Lo´pez I, Valdez-Gonza´lez N, Puerto-Solı´s M. High
prevalence of human papillomavirus type 58 in Mexican colposcopy patients. J
Clin Virol 2004;29:202–5.32. Delage M. La parentiﬁcation des enfants: un exemple d’adaptation dans les
familles de marins? Med Armees 2002;30:167–73.
33. Molano M, Huertas A, Herna´ndez G, Martin C, Me´ndez F, Bravo MM, et al.
Presence and persistence of E6/HPV16 variants in the Colombian cohort.
Abstract 7B-07, 104. 24th international papillomavirus conference and clinical
workshop. 2007.
34. Lizano M, De la Cruz-Herna´ndez E, Carrillo-Garcı´a A, Garcı´a-Carranca´ A,
Ponce de Leo´n-Rosales S, Duen˜as-Gonza´lez A, et al. Distribution of HPV16
and 18 intratypic variants in normal cytology, intraepithelial lesions,
and cervical cancer in a Mexican population. Gynecol Oncol 2006;102:
230–5.
35. Xi LF, Koutsky LA, HildesheimA, Galloway DA,Wheeler CM,Winer RL, et al. Risk
for high grade cervical intraepithelial neoplasia associated with variants of
human papillomavirus types 16 and 18. Cancer Epidemiol Biomarkers Prev
2007;16:4–10.
36. Berumen J, Ordon˜ez RM, Lazcano E, Salmeron J, Galvan SC, Estrada RA, et al.
Asian–American variants of human papillomavirus 16 and risk for cervical
cancer: a case-control study. J Natl Cancer Inst 2001;93:325–30.
